摘要：目的" 探讨白细胞预测急性心肌梗死(AMI)患者院内死亡的临床价值。方法" 回顾性分析2014年1月-2022年10月我院接受治疗的AMI患者507例，根据白细胞数量分为A组[白细胞数量(4～10)×109/L]和B组(白细胞数量gt;10×109/L)，比较两组一般资料、院内病死率，并采用COX回归分析AMI患者死亡的预测因素。结果" 两组白细胞数量、年龄、EF值、吸烟、术后他汀、服用血管活性药、MACE结果比较，差异有统计学意义(Plt;0.05);A组院内病死率为7.89‰，低于B组的92.70‰，差异有统计学意义(Plt;0.05)。白细胞、中性粒细胞、年龄、心衰、血管活性药物是影响AMI患者死亡的独立因素，即白细胞高是白细胞正常发生死亡概率的0.993倍，中性粒细胞高是中性粒细胞正常的1.052倍，年龄大是年龄小的1.060倍，发生心衰是不发生心衰的4.423倍，不使用血管活性药是使用血管活性药物的0.282倍。结论" 白细胞、中性粒细胞、年龄、心衰、血管活性药物是AMI死亡的预测因素，应用白细胞计数对患者结局的预测可以有助于临床决策。

    关键词：急性心肌梗死;白细胞;预后

    中图分类号：R541.4" " " " " " " " " " " " " " " " "文献标识码：A" " " " " " " " " " " " " " " " "DOI：10.3969/j.issn.1006-1959.2024.15.026

    文章编号：1006-1959(2024)15-0115-04

    Clinical Value of White Blood Cells in Predicting In-hospital Death in Patients

    with Acute Myocardial Infarction

    Abstract：Objective" To investigate the clinical value of white blood cells in predicting in-hospital death in patients with acute myocardial infarction (AMI).Methods" A total of 507 patients with AMI who were treated in our hospital from January 2014 to October 2022 were retrospectively analyzed. According to the number of white blood cells ......